Transforming pharma R&D with a scientist-centric approach to AI & automation
pharmaphorum
JUNE 16, 2021
Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Markus Gershater co-founded Synthace after working as a research associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering.
Let's personalize your content